Clinical Trials
52 trialsMale Breast Cancer: Understanding the Biology for Improved Patient Care
European Organisation for Research and Treatment of Cancer - EORTC
Follow-up in Early and Locally Advanced Breast Cancer Patients
European Organisation for Research and Treatment of Cancer - EORTC
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
Eastern Cooperative Oncology Group
COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation
Eastern Cooperative Oncology Group
The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer
Cancer Trials Ireland
Developing a Comprehensive Exercise Service for Breast Cancer Process
GO fit Lab- Ingesport
Breast Cancer Proteomics and Molecular Heterogeneity
Cancer Trials Ireland
TAILORx Tissue Bank
Cancer Trials Ireland
Circulating miRNAs.
Cancer Trials Ireland
Ovarian Reserve in Premenopausal Breast Cancer
Cancer Trials Ireland
Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer
Cancer Trials Ireland
Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion Protocol
Eastern Cooperative Oncology Group
AXSANA
European Breast Cancer Research Association of Surgical Trialists
MELODY
European Breast Cancer Research Association of Surgical Trialists
RELIEF-COHORT
Meshalkin Research Institute of Pathology of Circulation
MINDACTRelapse
European Organisation for Research and Treatment of Cancer - EORTC
Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3
Canadian Cancer Trials Group
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Eastern Cooperative Oncology Group
Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
Eastern Cooperative Oncology Group
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
Eastern Cooperative Oncology Group
Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
Eastern Cooperative Oncology Group
Real-World Data on Clinical Characteristics, Demographics, and Outcomes of Patients With Metastatic Breast Cancer in Turkey
Turkish Oncology Group
Preoperative Radiotherapy and Systemic Therapy Following Surgery in 'de Novo' Metastatic Breast Cancer
Ankara Oncology Research and Training Hospital
SOLE-EST
ETOP IBCSG Partners Foundation
Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast Cancer
NSABP Foundation Inc
NSABP Biospecimen Discovery Project
NSABP Foundation Inc
Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
GOG Foundation
S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313
SWOG Cancer Research Network
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
SWOG Cancer Research Network
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
European Organisation for Research and Treatment of Cancer - EORTC
Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
GOG Foundation
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
Cancer Trials Ireland
Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy
Eastern Cooperative Oncology Group
Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer
Eastern Cooperative Oncology Group
Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ
Eastern Cooperative Oncology Group
Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
Eastern Cooperative Oncology Group
SWOG 8897-A DNA Analysis in Predicting Treatment Outcome in Women With Breast Cancer in SWOG 8897
SWOG Cancer Research Network
S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
SWOG Cancer Research Network
SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial
SWOG Cancer Research Network
Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
NSABP Foundation Inc
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2
NSABP Foundation Inc
Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28
NSABP Foundation Inc
Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial
NSABP Foundation Inc
ABC Survey - do we Meet the Needs of Patients With Advanced Breast Cancer?
Cancer Trials Ireland
CADY Study ICORG 08-01
Cancer Trials Ireland
S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313
SWOG Cancer Research Network
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil
SWOG Cancer Research Network
S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307
SWOG Cancer Research Network
Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100
Eastern Cooperative Oncology Group